| 0 (0%) | 10-15 12:18 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 154.84 | 1-year : | 180.85 |
| Resists | First : | 132.57 | Second : | 154.84 |
| Pivot price | 129.47  |
|||
| Supports | First : | 128.1 | Second : | 125.34 |
| MAs | MA(5) : | 128.25 |
MA(20) : | 129.62 |
| MA(100) : | 126.5 |
MA(250) : | 124.97 |
|
| MACD | MACD : | -0.3 |
Signal : | 0 |
| %K %D | K(14,3) : | 53.3 |
D(3) : | 36.6 |
| RSI | RSI(14): 49.7 |
|||
| 52-week | High : | 136.41 | Low : | 102.23 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ IJJ ] has closed above bottom band by 47.9%. Bollinger Bands are 7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 130.12 - 130.62 | 130.62 - 131.2 |
| Low: | 125.34 - 125.88 | 125.88 - 126.49 |
| Close: | 128.51 - 129.38 | 129.38 - 130.38 |
Wed, 15 Oct 2025
Can IJJ stock surprise markets with earnings - 2025 Bull vs Bear & Verified Entry Point Signals - newser.com
Tue, 14 Oct 2025
IJJ: Diversified Mid-Cap Exposure With A Tilt To Financials (NYSEARCA:IJJ) - Seeking Alpha
Tue, 22 Jul 2025
Are viral vector-mediated therapies compatible with aberrant glycosylation? - ScienceDirect.com
Tue, 24 Jun 2025
IJJ: Mid-Cap Value Category Is Likely To Thrive, Consider For Long-Term Investment - Seeking Alpha
Sat, 29 Mar 2025
IJJ ETF: A Solid Way To Play Mid-Caps (NYSEARCA:IJJ) - Seeking Alpha
Wed, 05 Feb 2025
ETF Flowdown: Off to the Races in 2025 - ETF Trends
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|